US Patent 11779549 Treatment of Fragile X Syndrome with cannabidiol
Patent 11779549 was granted and assigned to Zynerba Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+31 properties)
Article (+313 characters)
US Patent 11779549 Treatment of Fragile X Syndrome with cannabidiol
Article
Patent abstract
The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Donna Gutterman
John Messenheimer
Marcel Bonn-Miller
Nancy Tich
Terri Sebree
Date of Patent
October 10, 2023
Patent Application Number
17895008
Date Filed
August 24, 2022
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11779549 Treatment of Fragile X Syndrome with cannabidiol
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
